Left ventricular geometry in children with mild to moderate chronic renal insufficiency

Journal of the American Society of Nephrology

Volumn 17, Issue 1, 2006, Pages 218-226

  Matteucci, Maria Chiara ^a   Wühl, Elke ^b   Picca, Stefano ^a   Mastrostefano, Antonio ^a   Rinelli, Gabriele ^a   Romano, Carmela ^c   Rizzoni, Gianfranco ^a   Mehls, Otto ^b   De Simone, Giovanni ^c   Schaefer, Franz ^b,d  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b Center for Pediatrics and Adolescent Medicine   (Germany)

^c FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; SERUM ALBUMIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CHILD; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GEOMETRY; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; SEX DIFFERENCE; STANDARDIZATION;

EID: 33645452927     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005030276     Document Type: Article

References (53)

1. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10: 1606-1615, 1999
2. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS: Mortality and cause of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int 61: 621-629, 2002
3. Oh J, Wunsch R, Turzer M, Banner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106: 100-105, 2002
4. Parekh RS, Caroll CE, Wolfe RA, Port FK: Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141: 191-197, 2002
5. London GM: Cardiovascular disease in chronic renal failure: Pathophysiologic aspects. Semin Dial 16: 85-94, 2003
6. Wheeler DC, Townend JN, Landray MJ: Cardiovascular risk factors in predialysis patients: Baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Kidney Int Suppl 63[Suppl 84]: S201-S203, 2003
7. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF: Severe left ventricular hypertrophy in pediatric dialysis: Prevalence and predictors. Pediatr Nephrol 14: 898-902, 2000
8. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol 13: 1918-1927, 2002
9. Gruppen MP, Groothoff JW, Prins M, van der Wouw P, Offringa M, Bos WJ, Davin JC, Heymans HS: Cardiac disease in young adult patients with end-stage renal disease since childhood: A Dutch cohort study. Kidney Int 63: 1058-1065, 2003
10. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990
11. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290, 1989
12. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Ciacone G, Stancanelli B, Catalioto A, Malatino LS: Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression. Kidney Int 65: 1492-1498, 2004
13. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995
14. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354, 1996
15. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR: Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50: 998-1006, 1996
16. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR: Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107: 864-868, 2003
17. Wuhl E, Mehls O, Schaefer F; ESCAPE trial group: Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66: 768-776, 2004
18. de Simone G, Mureddu G, Greco R, Scalfi L, Del Puente AE, Franzese A, Contaldo F, Devereux RB: Relations of left ventricular geometry and function to body composition in children with high casual blood pressure. Hypertension 30: 377-382, 1997
19. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978
20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux RB, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367, 1989
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57: 450-458, 1986
22. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdeccia P, Palmieri V, Agabiti-Rosei E, Mancia G: Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: The RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. J Hypertens 17: 1955-1963, 1999
23. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH: Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20: 1251-1260, 1992
24. Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA: Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76: 699-701, 1995
25. de Simone G, Daniels SR, Kimball TR, Roman MJ, Romano C, Chinali M, Galdeirsi M, Devereux RB: Evaluation of concentric left ventricular geometry in humans: Evidence for age-related systematic underestimation. Hypertension 45: 64-68, 2005
26. Teichholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 37: 7-11, 1976
27. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F: Distribution of 24-h ambulatory blood pressure in children: Normalized reference values and role of body dimensions. German Working Group on Pediatric Hypertension. J Hypertens 20: 1995-2007, 2002
28. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 34: 571-590: 571-590, 1987
29. Prader A, Largo RH, Molinari L, Issler C: Physical growth in Swiss children from birth to 20 years of age. Helv Paediatr Acta 52: S1-S125, 1989
30. Schaefer F, Georgi M, Wuhl E, Scharer K: Body mass index and percentage fat mass in healthy German schoolchildren and adolescents. M J Obes Relat Metab Disord 22: 461-469, 1998
31. Hanevold C, Waller J, Daniels S, Portman R, Sorof JM: International Pediatric Hypertension Association: The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: A collaborative study of the International Pediatric Hypertension Association. Pediatrics 113: 328-333, 2004
32. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS: Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation 91: 2400-2406, 1995
33. de Simone G, Kizer J, Chinali M, Roman MJ, Bella JN, Best LG, Lee ET, Devereux RB: Normalization for body size and population attributable risk of left ventricular hypertrophy: The Strong Heart Study. Am J Hypertens 18: 191-196, 2005
34. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR: Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 65: 1461-1466, 2004
35. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AE, Baker LR: Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 12: 724-728, 1997
36. Grossman W, Jones D, McLaurin LP: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56: 56-64, 1975
37. Schaefer F, Mehls O: Hypertension in chronic kidney disease. In: Pediatric Hypertension, edited by Portman RJ, Sorof JM, Ingelfinger JR, Totowa, NJ, Humana Press, 2004, pp 371-387
38. Gardner JD, Brower GL, Janicki JS: Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail 8: 101-107, 2002
39. Weinberg EO, Mirotsou M, Cannon J, Dzau VL, Lee RT, Pratt RE: Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics 12: 113-127, 2003
40. Alfakih K, Maqbool A, Sivananthan M, Walters K, Bainbridge G, Ridgway J, Balmforth AJ, Hall AS: Left ventricle mass index and the common, functional, x-linked angiotensin II type-2 receptor gene polymorphism (-1332 G/A) in patients with systemic hypertension. Hypertension 43: 1189-1194, 2004
41. van Kesteren CA, can Heugten HA, Lamers JM, Saxena PR, Schalekamp MA, Danser AH: Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 29: 2147-2157, 2005
42. Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, Berenson GS: Childhood adiposity as a predictor of cardiac mass in adulthood: The Bogalusa Heart Study. Circulation 110: 3488-3492, 2004
43. Fox E, Taylor H, Andrew M, Han H, Mohamed E, Garrison R, Skelton T: Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) Study. Hypertension 44: 55-60, 2004
44. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34: 125-134, 1999
45. Amann K, Wiest G, Klaus G, Ritz E, Mall G: A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4: 1814-1819, 1994
46. Pecoits-Filho R, Lindholm B, Stenvinkel P: The malnutrition, inflammation and atherosclerosis (MIA) syndrome-The heart of the matter. Nephrol Dial Transplant 17[Suppl 18]: 28-31, 2002
47. Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, Sanderson JE: Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 15: 2186-2194, 2004
48. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J: Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 17: 229-232, 2004
49. Beddhu S: The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 17: 229-232, 2004
50. Olsen MH, Hjerkinn E, Wachtell K, Hoieggen A, Bella JN, Nesbitt SD, Possum E, Kjeldsen SE, Julius S, Ibsen H: Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: A LIFE substudy. J Hum Hypertens 17: 305-311, 2003
51. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001
52. Nitta K, Akiba T, Uchida K, Otsubo S, Otsubo Y, Takei T, Ogawa T, Yumura W, Kabaya T, Nihei H: Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res 27: 47-52, 2004
53. Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Schaefer F: Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16: 1494-1500, 2005